Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

Multiple pregnancies, hepatitis C, and risk for hepatocellular carcinoma in Egyptian women

Authors: Sania Amr, Emily A Iarocci, Ghada R Nasr, Doa’a Saleh, Jan Blancato, Kirti Shetty, Christopher A Loffredo

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

The reasons for the worldwide sex disparity in the incidence of hepatocellular carcinoma (HCC) remain elusive. We investigated the role of multiple pregnancies on the associations between viral hepatitis C (HCV) infection and HCC risk among Egyptian women.

Methods

We used data collected from blood specimens and questionnaires administered to female HCC cases and controls in Cairo, Egypt, from 1999 through 2009. HCV infection was defined as being sero-positive for either anti-HCV antibodies or HCV-RNA. Using logistic regression models we calculated odds ratios (OR) and 95% confidence intervals (CI) to estimate the associations between being HCV positive and HCC risk, and how it is modified by the number of pregnancies, after adjustment for other factors, including hepatitis B status.

Results

Among 132 confirmed female cases and 669 controls, the risk of HCV-related HCC increased with the number of pregnancies. Women infected with HCV had higher risk for HCC if they had more than five pregnancies, as compared to those who had five or fewer pregnancies (adjusted OR (95% CI): 2.33 (1.29-4.22)). The association of HCV infection with HCC risk was significantly greater among the former (21.42 (10.43-44.00)) than among the latter (6.57 (3.04-14.25)).

Conclusion

Having multiple pregnancies increases the risk of HCV-related HCC among Egyptian women, raising questions about the roles of estrogens and other pregnancy-related hormones in modulating HCV infection and its progression to HCC.
Literature
1.
go back to reference International Agency for Research on Cancer, and World Health Organization: GLOBOCAN 2012, estimated cancer incidence, and mortality and prevalence worldwide in 2012. 2013, Lyon: IARC, Available from: http://globocan.iarc.fr/Default.aspx. Accessed Dec 1 2014 International Agency for Research on Cancer, and World Health Organization: GLOBOCAN 2012, estimated cancer incidence, and mortality and prevalence worldwide in 2012. 2013, Lyon: IARC, Available from: http://​globocan.​iarc.​fr/​Default.​aspx. Accessed Dec 1 2014
2.
go back to reference Anwar WA, Khaled HM, Amra HA, El Nezami H, Loffredo CA: Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat Res. 2008, 659: 176-184. 10.1016/j.mrrev.2008.01.005.CrossRefPubMed Anwar WA, Khaled HM, Amra HA, El Nezami H, Loffredo CA: Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat Res. 2008, 659: 176-184. 10.1016/j.mrrev.2008.01.005.CrossRefPubMed
3.
go back to reference International Agency for Research on Cancer (IARC): Hepatitis Viruses. 1994, Lyon, France: IARC Monogr Eval Carcinog Risks Hum, 59: International Agency for Research on Cancer (IARC): Hepatitis Viruses. 1994, Lyon, France: IARC Monogr Eval Carcinog Risks Hum, 59:
4.
go back to reference Hassan MM, Zaghloul AS, El Serag HB, Soliman O, Patt YZ, Chappell CL, Beasley RP, Hwang L-Y: The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol. 2001, 33: 123-126. 10.1097/00004836-200108000-00006.CrossRefPubMed Hassan MM, Zaghloul AS, El Serag HB, Soliman O, Patt YZ, Chappell CL, Beasley RP, Hwang L-Y: The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol. 2001, 33: 123-126. 10.1097/00004836-200108000-00006.CrossRefPubMed
6.
go back to reference Thomas MB, Zhu AX: Hepatocellular carcinoma: the need for progress. J Clin Oncol. 2005, 23: 2892-2899. 10.1200/JCO.2005.03.196.CrossRefPubMed Thomas MB, Zhu AX: Hepatocellular carcinoma: the need for progress. J Clin Oncol. 2005, 23: 2892-2899. 10.1200/JCO.2005.03.196.CrossRefPubMed
7.
go back to reference Tan A, Yeh SH, Liu C-H, Cheung C, Chen P-J: Viral hepatocarcinogenesis: from infection to cancer. Liver Int. 2008, 28: 175-188. 10.1111/j.1478-3231.2007.01652.x.CrossRefPubMed Tan A, Yeh SH, Liu C-H, Cheung C, Chen P-J: Viral hepatocarcinogenesis: from infection to cancer. Liver Int. 2008, 28: 175-188. 10.1111/j.1478-3231.2007.01652.x.CrossRefPubMed
8.
go back to reference Bosch FX, Ribes J, Diaz M, Cleris R: Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004, 127: S5-S16. 10.1053/j.gastro.2004.09.011.CrossRefPubMed Bosch FX, Ribes J, Diaz M, Cleris R: Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004, 127: S5-S16. 10.1053/j.gastro.2004.09.011.CrossRefPubMed
9.
go back to reference Naugler WE, Sakurai T, Kim S, Maeda S, Kim KH, Elsharkawy AM, Karin M: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007, 317: 121-124. 10.1126/science.1140485.CrossRefPubMed Naugler WE, Sakurai T, Kim S, Maeda S, Kim KH, Elsharkawy AM, Karin M: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007, 317: 121-124. 10.1126/science.1140485.CrossRefPubMed
10.
go back to reference Yeh SH, Chen PJ: Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology. 2010, 78 (Suppl 1): 172-179.CrossRefPubMed Yeh SH, Chen PJ: Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology. 2010, 78 (Suppl 1): 172-179.CrossRefPubMed
11.
go back to reference Nakagawa H, Maeda S, Yoshida H, Tateishi R, Masuzaki R, Ohki T, Hayakawa Y, Kinoshita H, Yamakado M, Kato N, Shiina S, Omata M: Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. Int J Cancer. 2009, 125: 2264-2269. 10.1002/ijc.24720.CrossRefPubMed Nakagawa H, Maeda S, Yoshida H, Tateishi R, Masuzaki R, Ohki T, Hayakawa Y, Kinoshita H, Yamakado M, Kato N, Shiina S, Omata M: Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. Int J Cancer. 2009, 125: 2264-2269. 10.1002/ijc.24720.CrossRefPubMed
12.
go back to reference Yin PH, Lee HC, Chau GY, Liu TY, Liu HC, Lui WY, Chi CW: Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in Taiwan females. Cancer Lett. 2004, 212: 195-201. 10.1016/j.canlet.2004.04.032.CrossRefPubMed Yin PH, Lee HC, Chau GY, Liu TY, Liu HC, Lui WY, Chi CW: Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in Taiwan females. Cancer Lett. 2004, 212: 195-201. 10.1016/j.canlet.2004.04.032.CrossRefPubMed
13.
go back to reference Giannitrapani L, Soresi M, La Spada E, Cervello M, D’Alessandro N, Montalto G: Sex hormones and risk of liver tumor. Ann N Y Acad Sci. 2006, 1089: 228-236. 10.1196/annals.1386.044.CrossRefPubMed Giannitrapani L, Soresi M, La Spada E, Cervello M, D’Alessandro N, Montalto G: Sex hormones and risk of liver tumor. Ann N Y Acad Sci. 2006, 1089: 228-236. 10.1196/annals.1386.044.CrossRefPubMed
14.
go back to reference Yu MW, Chang HC, Chang SC, Liaw YF, Lin SM, Liu CJ, Lee SD, Lin CL, Chen PJ, Lin SC, Chen CJ: Role of reproductive factors in hepatocellular carcinoma: impact on hepatitis B- and C-related risk. Hepatology. 2003, 38: 1393-1400.PubMed Yu MW, Chang HC, Chang SC, Liaw YF, Lin SM, Liu CJ, Lee SD, Lin CL, Chen PJ, Lin SC, Chen CJ: Role of reproductive factors in hepatocellular carcinoma: impact on hepatitis B- and C-related risk. Hepatology. 2003, 38: 1393-1400.PubMed
15.
go back to reference Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo SH, Feinleib M, Chen CJ: Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study. J Natl Cancer Inst. 2009, 101: 1019-1027. 10.1093/jnci/djp146.CrossRefPubMed Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo SH, Feinleib M, Chen CJ: Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study. J Natl Cancer Inst. 2009, 101: 1019-1027. 10.1093/jnci/djp146.CrossRefPubMed
16.
go back to reference Chen B, Yang C-Y: Mortality from cancers of the digestive system among grand multiparous women in Taiwan. Int J Environ Res Public Health. 2014, 11: 4374-4383. 10.3390/ijerph110404374.CrossRefPubMedPubMedCentral Chen B, Yang C-Y: Mortality from cancers of the digestive system among grand multiparous women in Taiwan. Int J Environ Res Public Health. 2014, 11: 4374-4383. 10.3390/ijerph110404374.CrossRefPubMedPubMedCentral
17.
go back to reference La Vecchia C, Negr E, Franceschi S, Parazzini F: Long-term impact of reproductive factors on cancer risk. Int J Cancer. 1993, 53: 215-219. 10.1002/ijc.2910530207.CrossRefPubMed La Vecchia C, Negr E, Franceschi S, Parazzini F: Long-term impact of reproductive factors on cancer risk. Int J Cancer. 1993, 53: 215-219. 10.1002/ijc.2910530207.CrossRefPubMed
18.
go back to reference Ezzat S, Abdel-Hamid M, Eissa SA, Mokhtar N, Labib NA, El-Ghorory L, Mikhail NN, Abdel-Hamid M, Hifnawy T, Strickland T, Loffredo CL: Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. Int J Hyg Environ Health. 2005, 208: 329-339. 10.1016/j.ijheh.2005.04.003.CrossRefPubMed Ezzat S, Abdel-Hamid M, Eissa SA, Mokhtar N, Labib NA, El-Ghorory L, Mikhail NN, Abdel-Hamid M, Hifnawy T, Strickland T, Loffredo CL: Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. Int J Hyg Environ Health. 2005, 208: 329-339. 10.1016/j.ijheh.2005.04.003.CrossRefPubMed
19.
go back to reference Abdel-Hamid M, Edelman DC, Highsmith WE, Constantine NT: Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus. J Hum Virol. 1997, 1: 58-65.PubMed Abdel-Hamid M, Edelman DC, Highsmith WE, Constantine NT: Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus. J Hum Virol. 1997, 1: 58-65.PubMed
20.
go back to reference Chen JD, Chung JL, Kao JH, Chen DS: Post-partum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother. J Gastroenterol Hepatol. 2001, 16: 705-708. 10.1046/j.1440-1746.2001.02502.x.CrossRefPubMed Chen JD, Chung JL, Kao JH, Chen DS: Post-partum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother. J Gastroenterol Hepatol. 2001, 16: 705-708. 10.1046/j.1440-1746.2001.02502.x.CrossRefPubMed
21.
go back to reference Siiteri PK, Stites DP: Immunologic and endocrine interrelationships in pregnancy. Biol Reprod. 1982, 26: 1-14. 10.1095/biolreprod26.1.1.CrossRefPubMed Siiteri PK, Stites DP: Immunologic and endocrine interrelationships in pregnancy. Biol Reprod. 1982, 26: 1-14. 10.1095/biolreprod26.1.1.CrossRefPubMed
22.
go back to reference Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT: Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology. 2004, 112: 38-43. 10.1111/j.1365-2567.2004.01869.x.CrossRefPubMedPubMedCentral Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT: Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology. 2004, 112: 38-43. 10.1111/j.1365-2567.2004.01869.x.CrossRefPubMedPubMedCentral
23.
go back to reference Kayisli UA, Selam B, Guzeloglu-Kayisli O, Demir R, Arici A: Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system. J Immunol. 2003, 171: 2305-2313. 10.4049/jimmunol.171.5.2305.CrossRefPubMed Kayisli UA, Selam B, Guzeloglu-Kayisli O, Demir R, Arici A: Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system. J Immunol. 2003, 171: 2305-2313. 10.4049/jimmunol.171.5.2305.CrossRefPubMed
24.
go back to reference Chung RT, Evans SR, Yang Y, Theodore D, Valdez H, Clark R, Shikuma C, Nevin T, Sherman KE: AIDS clinical trials group 383 study team. Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects. AIDS. 2002, 16: 1915-1923. 10.1097/00002030-200209270-00008.CrossRefPubMed Chung RT, Evans SR, Yang Y, Theodore D, Valdez H, Clark R, Shikuma C, Nevin T, Sherman KE: AIDS clinical trials group 383 study team. Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects. AIDS. 2002, 16: 1915-1923. 10.1097/00002030-200209270-00008.CrossRefPubMed
25.
go back to reference Singh N, Perfect JR: Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis. 2007, 45: 1192-1199. 10.1086/522182.CrossRefPubMed Singh N, Perfect JR: Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis. 2007, 45: 1192-1199. 10.1086/522182.CrossRefPubMed
Metadata
Title
Multiple pregnancies, hepatitis C, and risk for hepatocellular carcinoma in Egyptian women
Authors
Sania Amr
Emily A Iarocci
Ghada R Nasr
Doa’a Saleh
Jan Blancato
Kirti Shetty
Christopher A Loffredo
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-893

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine